Yahoo Web Suche

Suchergebnisse

1. adrenomed.comAdrenomed – Adrenomed AG

   adrenomed.com

   • Im Cache

   AdrenoMed AG is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: developing precision medicine to rescue vascular integrity and saving the lives of critically ill patients with limited treatment options.

   • More Events

     The Adrenomed management team will be available for meetings...

   • More News

     Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief...

   • Imprint/Impressum

     AdrenoMed AG. Sitz der Gesellschaft: Hennigsdorf....

   • Legal

     AdrenoMed AG Neuendorfstraße 15a 16761 Hennigsdorf bei...

   • Publications

     BIOMARKER. van Lier et al. J Intern Med, 2021;289(6):792-806...

   • Media Coverage

     Watch: Adrenomed tackling huge issue of sepsis By Jim...

   • Jobs

     AdrenoMed Receives FDA Fast Track Designation for...

   • Download

     Adrenomed’s mission is to rescue vascular integrity and save...

2. www.dbi-ag.de › beteiligungen › adrenomedAdrecizumab - Sepsistherapie - Deutsche Biotech Innovativ AG

   www.dbi-ag.de › beteiligungen › adrenomed

   • Im Cache

   Adrecizumab ist ein humanisierter monoklonaler Antikörper, der das vasoaktive Peptidhormon Adrenomedullin hochspezifisch bindet, ohne seine biologische Aktivität zu blockieren. Adrenomedullin ist ein protektiver Faktor der Blutgefäßintegrität, der dem Austritt von Flüssigkeit aus dem Gefäßen entgegenwirkt.

3. adrenomed.com › adrenomed-receives-positive-ema-scientificAdrenomed Receives Positive EMA Scientific Advice for Further...

   adrenomed.com › adrenomed-receives-positive-ema-scientific

   • Im Cache

   2. Dez. 2021 · Adrenomed develops Adrecizumab, a first-in-class antibody that targets adrenomedullin to restore vascular integrity in patients with early septic shock. The company received positive feedback from EMA for its pivotal trial design and plans to attend J.P. Morgan Healthcare Conference 2022.

4. adrenomed.com › category › newsNews – Adrenomed

   adrenomed.com › category › news

   • Im Cache

   13. Okt. 2022 · Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer Hennigsdorf/Berlin (Germany), June 23, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. med. Steffen Stürzebecher as Chief Medical Officer (CMO) of Adrenomed, effective June 20, 2022. Dr. Stürzebecher is Read More »

5. de.linkedin.com › company › adrenomed-agAdrenomed AG | LinkedIn

   de.linkedin.com › company › adrenomed-ag

   Adrenomed AG is a German privately financed, clinical-stage biopharmaceutical company. Adrenomed’s mission is to rescue vascular integrity in order to save the lives of critically ill...

6. www.dbi-ag.de › aktuelles › pressemitteilungenBeteiligungsunternehmen Adrenomed erhält positiven Scientific...

   www.dbi-ag.de › aktuelles › pressemitteilungen

   • Im Cache

   Adrenomed verfolgt einen neuen Therapieansatz, um die Integrität und Barrierefunktion der Blutgefäße zu sichern. Diese können bei schweren, bislang unzureichend behandelbaren Erkrankungen durchlässiger werden, so dass es zu lebensbedrohlichen Ödemen und Schock kommen kann.

7. european-biotechnology.com › up-to-date › latest-newsAdrenomed set to start pivotal trial in sepsis

   european-biotechnology.com › up-to-date › latest-news

   • Im Cache

   18. Okt. 2022 · German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.